Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report

BACKGROUND: A variety of immune-modulating drugs are becoming increasingly used for various cancers. Despite increasing indications and improved efficacy, they are often associated with a wide variety of immune mediated adverse events including colitis that may be refractory to conventional therapy....

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:World J Gastrointest Pharmacol Ther
Main Authors: Nassri, Ammar B, Muenyi, Valery, AlKhasawneh, Ahmad, Ribeiro, Bruno De Souza, Scolapio, James S, Malespin, Miguel, de Melo Jr, Silvio W
פורמט: Artigo
שפה:Inglês
יצא לאור: Baishideng Publishing Group Inc 2019
נושאים:
Case Report
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6347649/
https://ncbi.nlm.nih.gov/pubmed/30697447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v10.i1.29
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים